Get Started

AVLN

NASD Avalyn Pharma Inc
Oct 30, 2026 · 9:32 PM ET EOD Market Closed

$25.63 ↑ +0.00 (+0.00%) Trading Up from the previous close of $25.63, $0.54 below the day’s high of $26.17

YTD change
-14.11%
vs 20-day SMA
+0.73%
vs 200-day SMA
N/A

Price ranges

Previous day
$25.17 $26.20
open $26.09 close $25.71
-$0.38 (-1.46%)
Today
$24.85 $26.17
open $25.71 now $25.63
-$0.08 (-0.31%)
Past week
$24.82 $28.52
from $27.25 now $25.63
-$1.62 (-5.94%)
Past month
$22.24 $28.92
from $27.42 now $25.63
-$1.79 (-6.53%)
This year
$22.24 $40.17
from $29.84 now $25.63
-$4.21 (-14.11%)

Price & Performance

-4.21 (-14.11%) / 6M

$22.06$28.21$34.37$40.52May 1Aug 3Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 36.2% away from all-time highs of $40.17
  • AVLN is down 14% since the beginning of the year
  • AVLN is down 14% over the past 12 months
  • AVLN is down 7% over the past 1 month
  • 9% of all AVLN investors are betting against AVLN

AVLN reads not so good: the 12-month move is -14.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.98
Earnings momentum -37.4% Quarterly EPS growth
Quarterly change -37.4%

Valuation

P/E ratio N/A
Enterprise value $804.5M
Beta 1.23

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$352.4M
Debt$17.1K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $1.1B

Avalyn Pharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). The company was founded by Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar on May 27, 2011 and is headquartered in Boston, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $466.01 +1.15%
MRNA Moderna, Inc. $221.72 -0.47%
RVMD Revolution Medicines, Inc. $191.31 +0.55%
ROIV Roivant Sciences Ltd. $36.91 -1.63%
BNTX BioNTech SE Sponsored ADR $88.17 -1.08%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.